Figure 7. Abatacept combined with methotrexate versus single DMARD (methotrexate): The effect of abatacept was significant (Z = 3.08).

The 2 abatacept studies showed no heterogeneity (I2 = 0).

The 2 abatacept studies showed no heterogeneity (I2 = 0).